Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001179110-18-009834

Chief Technology Officer sold 14,000 shares at an average $35.63 ($498,872)

  • Chief Technology Officer acquired 14,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Myer Vickesh · Chief Technology Officer

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2018-07-17 Exercise or conversion : show line 1 in the form +3,000 $0.65 $1,950 3,000 D
2018-07-17 Sale : show line 2 in the form −3,000 $34.66 $103,980 0 D
2018-07-17 Exercise or conversion : show line 3 in the form +4,000 $0.65 $2,600 4,000 D
2018-07-17 Sale : show line 4 in the form −4,000 $36.50 $146,000 0 D
2018-07-18 Exercise or conversion : show line 5 in the form +6,150 $11.21 $68,942 6,150 D
2018-07-18 Sale : show line 6 in the form −6,150 $35.46 $218,079 0 D
2018-07-18 Exercise or conversion : show line 7 in the form +850 $11.21 $9,529 850 D
2018-07-18 Sale : show line 8 in the form −850 $36.25 $30,813 0 D
Open-market sales · 14,000 sh · avg $35.63 · $498,872

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2018-07-17 Exercise or conversion : show line 9 in the form Stock Option (right to buy) −7,000 97,307 D
2018-07-18 Exercise or conversion : show line 10 in the form Stock Option (right to buy) −7,000 76,897 D
Loading xslF345X03/edgar.xml…